Jorge Gomez-Mayorga

Dr. Jorge Gomez-Mayorga

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 June 2024 in Journal of Vascular Surgery
Verified
Journal Article
Closed access
TMTim J. Mandigers
Tim J. Mandigers
SASara Allievi
Sara Allievi
GJGabriel Jabbour
Gabriel Jabbour
JGJorge Gomez-Mayorga
Jorge Gomez-Mayorga
ECElisa Caron
Elisa Caron
MSMarc L. Schermerhorn
Marc L. Schermerhorn

23 August 2024 in Journal of Vascular Surgery
Verified
Journal Article
Closed access
ASAndrew P. Sanders
Andrew P. Sanders
JGJorge Gomez-Mayorga
Jorge Gomez-Mayorga
MMMohit K. Manchella
Mohit K. Manchella
NSNicholas J. Swerdlow
Nicholas J. Swerdlow
MSMarc L. Schermerhorn
Marc L. Schermerhorn

8 May 2024 in Journal of Vascular Surgery
Verified
Journal Article
Closed access
JGJorge Gomez-Mayorga
Jorge Gomez-Mayorga
SYSai Divya Yadavalli
Sai Divya Yadavalli
SASara Allievi
Sara Allievi
SWSophie X. Wang
Sophie X. Wang
VRVinamr Rastogi
Vinamr Rastogi
MSMarc L. Schermerhorn
Marc L. Schermerhorn

25 June 2025 in Cancer
Verified
Journal Article
Closed access
LBLeanne M. Brown
Leanne M. Brown
SWSarah G. Wilkins
Sarah G. Wilkins
VBVarun Bansal
Varun Bansal
DSDavid G Su
David G Su
JGJorge Gomez-Mayorga
Jorge Gomez-Mayorga
PGPeritoneal Surface Malignancies Consortium Group
Peritoneal Surface Malignancies Consortium Group

3 September 2024 in Journal of Vascular Surgery
Verified
Journal Article
Closed access
SSSabrina Straus
Sabrina Straus
JGJorge Gomez-Mayorga
Jorge Gomez-Mayorga
ASAndrew P. Sanders
Andrew P. Sanders
SYSai Divya Yadavalli
Sai Divya Yadavalli
SASara Allievi
Sara Allievi
MSMarc L. Schermerhorn
Marc L. Schermerhorn

21 November 2024 in Biomolecules
Verified
Journal Article
Open access
PDF file
JBJordan Broekhuis
Jordan Broekhuis
DLDongli Lu
Dongli Lu
RARajindra Aryal
Rajindra Aryal
YMYasuyuki Matsumoto
Yasuyuki Matsumoto
LPLauren Pepi
Lauren Pepi
Richard D. CummingsRichard D. Cummings
Richard D. Cummings
Aberrant protein glycosylation is a hallmark alteration of cancer and is highly associated with cancer progression. Papillary thyroid cancer (PTC) is the most common type of thyroid cancer, but the N-glycosylation of its glycoproteins has not been well characterized. In this work, we analyzed multiple freshly prepared PTC specimens along with paired normal tissue obtained from thyroidectomies. Glycomic analyses focused on Asn-linked (N)-glycans and employed mass spectrometry (MS), along with Western blot approaches of total solubilized materials that were examined for binding by specific lectins and a monoclonal antibody (mAb) O6, specific for 3-O-sulfated galactose residues. We observed major differences in PTC versus paired normal specimens, as PTC specimens exhibited higher levels of N-glycan branching and bisection with N-acetylglucosamine residues, consistent with RNAseq data. We also found that 3-O-sulfated galactose was present in N-glycans of multiple glycoproteins from both PTC and control specimens, as recognized by the O6 mAb and as confirmed by MS analyses. These results provide new insights into the N-glycans present in glycoproteins of thyroid cancer and context for further studies of these altered glycans as biomarkers and targets for therapeutics.